The Protocol Review Committee (PRC) is a multidisciplinary standing Committee of the UNC Lineberger Comprehensive Cancer Center and the UNC Clinical Cancer Program; a joint entity of UNC Lineberger, UNC Hospitals and the UNC School of Medicine. The PRC’s responsibility is the peer review of local and national research protocols involving cancer patients PRIOR to submission of the protocol to the UNC Institutional Review Board (IRB). The PRC’s primary function is to ensure the scientific quality and patient safety of proposed studies. The PRC also monitors study accrual and recommends closure of under-performing trials (via annual renewal review).
The PRC reviews any protocol which involves interaction with the UNC cancer population, or studies with a focus on cancer, regardless of whether it qualifies for expedited IRB review or requests for IRB exemption.
For PRC Meeting dates and deadlines for submission, please see the PRC Calendar
There are four types of submissions reviewed by the PRC: Letters of Intent (LOI), new submissions, annual renewals, and amendments. Please view the appropriate links below for information about the forms required for each type of submission.
I. LETTERS OF INTENT - Please note: Studies will no longer require a presubmission on an LOI prior to protocol submission. LOI's will be reviewed at a full PRC Meeting (with a single Member providing a review), and will function as a tool to provide scientific input, guidance, and other input from the PRC for those who are unfamiliar with the protocol process, or would like additional assistance at the outset of the protocol.
II. NEW STUDIES
III. RENEWALS- open to accrual and closed to accrual but with patients still under active treatment/intervention
A. CLOSED TO ACCRUAL (active intervention with patients completed) - For record keeping purposes only, please send the PRC one copy of all closed to accrual (CTA) reports.We will include this information in our meetings, for notification purposes only.
B. COMPLETED- For record keeping purposes only, please send the PRC one copy of all completion notices. We will include this information in our meetings, for notification purposes only.
IV. AMENDMENTS THAT AFFECT THE SCIENCE OF A STUDY - Amendment affecting the science of a study. PLEASE NOTE:
If this study is run under an IND, submission of this amendment to the FDA may be required, per 21CFR312.30 (b). Please review the following criteria and submit accordingly:
Please address all questions regarding the above to the PRC Coordinator.